发明名称 USE OF TERMINALIA CHEBULA EXTRACT FOR TREATMENT OF OSTEOARTHRITIS
摘要 The present invention provides an optimized and/or enriched hydrolyzable tannoid blend derived from Terminalia chebula. In an embodiment the present invention further relates to the use of an extract of Terminalia chebula for treatment of osteoarthritis. In another embodiment, a T. chebula extract composition contains about 8-25% by weight chebulagic acid, about 15-30% by weight chebulinic acid and about 10-40% by weight other low molecular weight hydrolyzable tannoids. This embodiment provides a T. chebula enriched tannoid blend composition (TC/enriched tannoid blend). In another embodiment, a method of treating osteoarthritis in an individual is provided, comprising administering to the individual in need thereof a therapeutically effective amount of the T. chebula extract composition. In yet another embodiment, a method of reducing pain and inflammation in an individual afflicted with osteoarthritis is provided, comprising orally administering to the individual in need thereof a therapeutically effective amount of the T. chebula extract composition.
申请公布号 US2015174184(A1) 申请公布日期 2015.06.25
申请号 US201414578793 申请日期 2014.12.22
申请人 Natreon, Inc. 发明人 Kalidindi Sanyasi R.
分类号 A61K36/185;A61K31/7048 主分类号 A61K36/185
代理机构 代理人
主权项 1. A method of treating osteoarthritis in a mammal, comprising administering to the mammal in need thereof a therapeutically effective amount of a Terminalia chebula extract composition comprising a hydrolyzable tannoid blend including about 8-25% by weight chebulagic acid based on the total weight of the extract, and about 15-30% by weight chebulinic acid based on the total weight of the extract.
地址 New Brunswick NJ US